fda semaglutide compounding news issues warning about some compounded versions of for diabetes, weight loss The End of Compounded Semaglutide:

Conversely, other satiety signals induced by gut-brain peptides such as GLP-1 [13-15], GLP-2 [40] and cholecystokinin produced a short-term effect, while insulin and leptin [41] inhibit the appetite by increasing the formation of pro-opiomelanocortin (POMC) and reducing NPY action

Nutritional management of dumping syndrome associated with antireflux surgery

doi:10.1038/s41591-018-0222-4 69

BPC-157 is used to support the treatment of gastroesophageal reflux disease , because thanks to its regulatory abilities, it influences the regulation of pressure inside the esophagus, concerning the lower esophageal sphincter and the pyloric sphincter, which means the peptide can be used both in preventive therapy and as an adjunct in treating gastroesophageal reflux disease, leading to its inhibition and the disappearance of related symptoms